GAMCO Investors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

GAMCO Investors’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-97,140	Closed	-$4.66M	–	913
2020 Q1	$4.66M	Buy	97,140 +40,441	+71%	+$1.88M	0.06%	314
2019 Q4	$2.66M	Buy	+56,699	New	+$2.51M	0.02%	454

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

GAMCO Investors's RARX Position: Q2 2020 in Review

GAMCO Investors sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 97,140 shares — an estimated $4.66M sold.

GAMCO Investors first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $4.66M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

GAMCO Investors reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
GAMCO Investors sold 97,140 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $4.66M.
GAMCO Investors first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
GAMCO Investors's Ra Pharmaceuticals, Inc. Common Stock position peaked at $4.66M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on GAMCO Investors's 13F filing for Q2 2020, filed 13 Aug 2020.